A Prospective, Randomised, Double-blind, Placebo-controlled, International, Multicentre, Parallel-group Comparison Trial Evaluating the Efficacy and Safety of Tenecteplase During Cardiopulmonary Resuscitation as Compared With Standard Treatment in Patients Suffering From Out-of-hospital Cardiac Arrest of Presumed Cardiac Origin Thrombolysis in Cardiac Arrest (TROICA) Trial

Trial Profile

A Prospective, Randomised, Double-blind, Placebo-controlled, International, Multicentre, Parallel-group Comparison Trial Evaluating the Efficacy and Safety of Tenecteplase During Cardiopulmonary Resuscitation as Compared With Standard Treatment in Patients Suffering From Out-of-hospital Cardiac Arrest of Presumed Cardiac Origin Thrombolysis in Cardiac Arrest (TROICA) Trial

Discontinued
Phase of Trial: Phase III

Latest Information Update: 28 Oct 2013

At a glance

  • Drugs Tenecteplase (Primary)
  • Indications Heart arrest; Thrombosis
  • Focus Therapeutic Use
  • Acronyms TROICA
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 18 Dec 2008 Results published in the New England Journal of Medicine.
    • 18 Dec 2008 Secondary endpoint 'Neurological parameters' has not been met, according to results published in the New England Journal of Medicine..
    • 18 Dec 2008 Secondary endpoint 'Hospitalisation' has not been met, according to results published in the New England Journal of Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top